Drawing for BEEKLEY MEDICAL

USPTO serial 85237140

BEEKLEY MEDICAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BENJAMIN, SARA NICOLE
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEEKLEY MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark D. Giarratana, Esq.

MARK D. GIARRATANA, ESQ. MCCARTER & ENGLISH, LLP185 ASYLUM STHARTFORD, CT 06103-3408UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
011Air-activated heating ball for non-medical use by a technologist to warm their hands prior to medical examACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 17, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 17, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 21, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 21, 2012NOACCORRECTED NOA E-MAILED—
Nov 20, 2012EX1GSOU EXTENSION 1 GRANTED—
Nov 20, 2012DPCCDIVISIONAL PROCESSING COMPLETE—
Nov 16, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 15, 2012EXT1SOU EXTENSION 1 FILED—
Nov 15, 2012DRRRDIVISIONAL REQUEST RECEIVED—
Nov 15, 2012ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 15, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 20, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 20, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 29, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 9, 2012ALIEASSIGNED TO LIE—
Jan 26, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2012ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 9, 2011GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 9, 2011GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 9, 2011CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 16, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2011DOCKASSIGNED TO EXAMINER—
Feb 11, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 11, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance